European Archives - Page 600 of 1005 - European Medical Journal

A Clinical Review of Ventricular Arrhythmias in Patients with Congestive Heart Failure

Pump failure and sudden cardiac death are the leading causes of death in heart failure patients; sudden cardiac death accounts for 30–50% of deaths…

Metastases in Prostate Cancer: Online Conversations by Patients and Caregivers

The incidence of prostate cancer in the overall cancer population in western Europe is between 10% and 15%; it is the leading cause of non-cutaneous cancer in many parts of the world…

Portable Breath Monitor Can Diagnose Acute Respiratory Distress Syndrome

ACUTE respiratory distress syndrome (ARDS) can now be detected, quickly and accurately, by a breath analyser that has been developed by a team…

Steroid and Bronchodilator Inhalers Can Help Manage Mild Asthma

MILD ASTHMA in children can be managed when symptoms occur by the use of two inhalers: a steroid and bronchodilator…

EMJ Urology 7 [Suppl 3] 2019

About 15% of all cancer diagnoses in western Europe are for prostate cancer, and many cancer patients, caregivers, and healthcare professionals…

ESHRE 2019 – Interview – Prof Claire Roberts

An interview with Prof Claire Roberts, Lloyd Cox Professorial Research Fellow, University of Adelaide, at this year’s ESHRE congress in Vienna, Austria…

EMJ Interventional Cardiology 7 [Supplement 1] 2019

This review examines the evidence on long-term prognosis, state-of-the-art assessment and treatment strategies, and the overwhelming need for…

Microvascular Angina: Diagnosis, Assessment, and Treatment

This review examines the evidence on long-term prognosis, state-of-the-art assessment and treatment strategies, and the overwhelming need for standardisation of diagnostic pathways in this patient population.

Designing a new approach to UX

In an era when UX is becoming fundamental to businesses globally, the role of design teams in pharma companies is taking on a whole new meaning.

The developing world: an innovation hub

Many of the most transformative innovations are taking place in the developing world on an increasingly regular basis. This article explores this phenomenon in healthcare and the key lessons pharma can take when creating their own innovative products.